InvestorsHub Logo
Followers 79
Posts 24524
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Tuesday, 11/14/2017 7:58:11 AM

Tuesday, November 14, 2017 7:58:11 AM

Post# of 27431
CLSN - 2.12 Pre-market now at 2.20/2.25

Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.